Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001683168-24-001086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-20 | 2024-02-15+ | PHIO | Kontulis Caitlin | Sec, VP Fin, Admin | F - Tax | $0.6544 | -1,181 | 11.0K | -10% | -$772.88 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2024-02-15 | F | D | 658 | $0.65 | 11,501 | D | — | — | (F2) Includes shares of common stock underlying unvested restricted stock units. |
| 2 | Common | Common stock, $0.0001 par value | 2024-02-17 | F | D | 523 | $0.66 | 10,978 | D | — | — | (F2) Includes shares of common stock underlying unvested restricted stock units. |